| ５年生存率 （C22 肝癌-肝内胆管癌を含む） | |||||||||
|
|
|||||||||
| 進行度 | 経過年数 | 対象者数 | 死亡者数 | 中途打切数 | 追跡率 | 実測生存率 | |||
| StageⅠ | 1 | 3 | 0 | 2 | 33.33% | 100.00% | |||
| 2 | 1 | 0 | 0 | 33.33% | 100.00% | ||||
| 3 | 1 | 0 | 1 | 0.00% | - | ||||
| 4 | - | - | - | - | - | ||||
| 5 | - | - | - | - | - | ||||
| StageⅡ | 1 | 14 | 0 | 4 | 71.43% | 100.00% | |||
| 2 | 10 | 0 | 2 | 57.14% | 100.00% | ||||
| 3 | 8 | 0 | 2 | 42.86% | 100.00% | ||||
| 4 | 6 | 2 | 1 | 34.29% | 62.50% | ||||
| 5 | 3 | 0 | 1 | 22.86% | 62.50% | ||||
| StageⅢ | 1 | 10 | 2 | 2 | 77.14% | 77.78% | |||
| 2 | 6 | 1 | 2 | 51.43% | 58.33% | ||||
| 3 | 3 | 0 | 0 | 51.43% | 58.33% | ||||
| 4 | 3 | 1 | 0 | 51.43% | 38.89% | ||||
| 5 | 2 | 0 | 0 | 51.43% | 38.89% | ||||
| StageⅣ | 1 | 4 | 2 | 0 | 100.00% | 50.00% | |||
| 2 | 2 | 0 | 1 | 50.00% | 50.00% | ||||
| 3 | 1 | 0 | 0 | 50.00% | 50.00% | ||||
| 4 | 1 | 1 | 0 | 50.00% | 0.00% | ||||
| 5 | - | - | - | - | - | ||||
| ※Kaplan-Meier法により算出した。 | |||||||||